Compare Inovio Pharmaceuticals Inc (INO) vs ProShares Ultra Semiconductors (USD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs ProShares Ultra Semiconductors — how do they compare? Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M), while ProShares Ultra Semiconductors trades at $93.35. The key difference: ProShares Ultra Semiconductors is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| INO | USD | |
|---|---|---|
Market Cap | $78.55M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $2.87 | $113.53 |
52-Week Low | $0.66 | $40.97 |
Enterprise Value | $49.56M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INO trades at $0.772, up 4.83% in the last 24 hours, but technical indicators signal a bearish trend. The company shows minimal revenue of $65,340 in 2025 with a net loss of $84.95 million, though it has beaten EPS estimates in recent quarters. Key developments include an upcoming Q2 2026 earnings report on August 12, 2026, and a pending FDA decision on INO-3107 by October 30, 2026.
The outlook hinges on FDA approval of INO-3107, with a consensus price target of $3.25 implying significant upside. However, high cash burn, negative margins, and legal scrutiny pose substantial risks. Investors should weigh the binary event against persistent financial challenges.
USD stock trades at $94.74, up 6.35% over the past 24 hours, with a bullish technical signal driven by moving averages. The company has announced a dividend of $0.14 per share scheduled for June 30, 2026, providing income to shareholders. Recent news highlights include Wells Fargo's tokenized deposits initiative and various earnings reports from other firms, though specific financials for USD are not detailed in the provided data.
The outlook remains positive based on technical momentum, but fundamental data like P/E and revenue are unavailable, limiting valuation clarity. Key risks include market volatility and reliance on broader economic conditions. Investors should seek updated SEC filings for a comprehensive analysis of the company's financial health and growth prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About ProShares Ultra Semiconductors
USD is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Semiconductors™ Index. It is a tactical instrument designed for sophisticated traders looking to magnify short-term bullish views on the U.S. semiconductor industry, specifically focusing on large-cap leaders in the chip and equipment space.
Read more on USD →
